Pharmascience

Last updated
Pharmascience Inc.
Company type Private
Industry Pharmaceutical
Founded1983
FoundersMorris Goodman, Ted Wise
Headquarters Montreal, Quebec, Canada
Key people
David Goodman, CEO
ProductsGeneric & Branded Drugs
Revenue$485 million
Number of employees
1,600 [1]
Website pharmascience.com

Pharmascience Inc. is a Quebec-based pharmaceutical company founded by pharmacists Morris Goodman and Ted Wise in 1983. Pharmascience Inc. is headquartered in Montreal and distributes its products to more than 50 countries. [2] [3]

Contents

History

In 1983, Pharmascience Inc. was founded by two pharmacists, Morris Goodman and Ted Wise. Its research and development (R&D) activities started with a team of five employees. [4]

In 1988, Pharmascience Inc. acquired and opened a drug production facility in Montreal.

In 1994, the company began its international expansion and opened an office in Kiev, Ukraine. [5]

In 1995, Pharmascience Inc. partnered with Health Partners International of Canada (HPIC). Since then, the pharmaceutical company has donated $72 million worth of medicine.

In 1996, Pharmascience Inc. invested $2 million in the creation of modern research laboratories of a pilot production plant in Montreal. [6] In 1998, the company invested $8 million for the acquisition of a building intended to house its head office, administrative centre and operating activities, in the west end of Montreal. A year later, the organization invested $3 million to build an ultra-modern distribution centre, across from the Montreal head office. While working on the construction of the distribution centre in 1999, Pharmascience Inc. announced a total investment of $50 million to expand and modernize its infrastructure and create 200 new jobs over the next five years. [7] [8]

In 2000, Pharmascience Inc. implemented a partnership with the government (Investissement Québec and Emploi Québec).

In 2003, the company invested $12 million for the acquisition of PanGeo Pharma, a Quebec pharmaceutical company, [9] and hired approximately 125 employees.

In 2007, Pharmascience Inc. opened a representative office in Vietnam. The same year, the Pharmascience Inc and Centraide campaigns were launched.

In 2011, the organization invested $38 million to open new laboratories in Montreal, which created 180 jobs by the next year. [10] Also in 2011, Pharmascience Inc. acquired Aegera Therapeutics, a Montreal-based clinical-stage biotechnology company. [11]

In 2012, the company obtained its Class A Operational Excellence certification for customer service and also implemented its Next Generation Leaders (NGL) program.

The following year, Pharmascience Inc. inaugurated its new distribution centre in Dorval. [12] The same year, the company announced its association with the South Korean company Korea Kolmar Holdings, to create Pharmascience Korea and to distribute Canadian pharmaceuticals in South Korea in 2014. [13]

In 2014, Pharmascience Inc. acquired Uman Pharma Inc., a fully integrated company that develops, manufactures and markets generic injectable pharmaceutical products. [14] The same year, Pharmascience Inc. opened its office on the South Shore, in Candiac [15] and its office in Saudi Arabia.

In 2015, the company announced an investment program of $55.7 million by the end of 2016, to modernize its infrastructure and increase its research and development (R&D) capacity. [16] [17]

In 2019, Pharmascience Inc. signed a partnership agreement with the PHOENIX group in Mannheim, Germany. Additionally, the organization launched its Royalmount Laboratories division in Montreal, a division specialized in bioanalytics and cannabis testing. [18] Also in 2019, Pharmascience Inc. signed a partnership agreement with Sama AlFayhaa, the largest pharmaceutical company in southern Iraq, in the same year. [19]

About Pharmascience Inc.'s Founders and CEOs

Dr. Morris Goodman

Morris Goodman, born in 1931 in Montreal to Ukrainian parents, [20] is a figure of Canadian entrepreneurship and a pioneer of the generic drug industry. [21]

Morris Goodman studied pharmacy at University of Montreal, in the same class as Jean Coutu. He completed his studies in 1953, at the age of 21. While he was still in university, he founded his first pharmaceutical distribution company with a friend: Winley-Morris. [21]

After graduating, Dr. Goodman became interested in the industrial side of pharmacy. Soon after, several international companies granted him distribution rights to market their products in the Canadian market, which he marketed under the name Winley-Morris Co. Ltée. In 1953, he was offered to distribute a treatment for tuberculosis. [20]

In 1971, he approached the California-based International Chemical & Nuclear Corporation (ICN) and became the Canadian distributor of L-dopa. Impressed by his innovative approach, ICN purchased Winley-Morris and offered Morris Goodman the presidency of ICN Canada. Goodman spent a total of 12 years working at ICN Canada. [22]

In 1983, at the age of 52, Dr. Goodman founded Pharmascience Inc. with his friend and colleague Ted Wise. Serving as both the co-founder and chairman of the board, he is behind the significant growth of the company, which is today one of the three largest generic pharmaceutical companies in Canada and the largest pharmaceutical employer in Quebec today. [22] [23]

Dr. Goodman has always been a philanthropist, in addition to being a pharmacist and businessman. Through the Morris & Rosalind Goodman Foundation, the foundation created by Dr. Goodman and his wife Rosalind in 2005, [24] he financed, among other projects, The Stroke Unit at the Jewish General Hospital of Montreal, the Agora at the Faculty of Pharmacy at the University of Montreal, and The Rosalind & Morris Goodman Cancer Research Centre at McGill University, [25] [26] as well as, more recently, the CHU Sainte-Justine's Goodman Pediatric Formulations Centre.

In 2015, Morris Goodman published his book “To Make a Difference,” an autobiography that includes testimonials about his colleagues and collaborators. [27]

Ted Wise

Ted S. Wise, who passed away in 2013, was a pharmacist. He co-founded Pharmascience Inc. in 1983 and also served as chairman and vice chairman of the board of directors. He was chairman of the board of directors and independent director of Paladin Labs Inc. from 1995 until 2012, when he was named chairman emeritus.

Dr. Goodman obtained his bachelor's degree in commerce from McGill University, and his Ph.D. in pharmacology from the University of Virginia. Upon graduation, he began his career at Pharmascience in Business Development, before taking charge of the future of the company, both in Canada and internationally.

Under Goodman's leadership and thanks to his investment in internal and external research and development (R&D) programs, Pharmascience Inc. has grown from a Canadian company to an international leader in the market.

David Goodman

David Goodman is President and CEO of Pharmascience Inc. [28]

Dr. Goodman holds a Bachelor of Commerce degree from McGill University and a PhD in Pharmacology from the University of Virginia. After graduating, he began his career at Pharmascience in business development, before taking charge of the company's future, both in Canada and abroad.

Under Mr. Goodman's leadership, and thanks to his investment in internal and external research and development (R&D) programs, Pharmascience Inc. has grown from a Canadian company to an international market leader.

Commercial Business Divisions

Pharmascience Canada

Pharmascience Canada is a division of Pharmascience Inc. which has two types of products: private labels and Over-the-Counter drugs (OTC).

Pharmascience Canada provides private label non-prescription drugs to major Canadian grocery and drugstore chains, as well as to distributors. It markets more than 20 brands across different product categories, mainly gastrointestinal (GI) and Cough & Cold.

The division also manufactures different OTC brands: Prospan by Helixia, Lax A Day, [29] Hemovel, Rhinaris and Pediatric Electrolyte for Kids.

Pharmascience International

Pharmascience International is a division of Pharmascience Inc., a full-service pharmaceutical company that develops and supplies high-quality products to patients and healthcare professionals in over 60 countries.

Pharmascience International has a direct presence in the following countries: Vietnam, Kingdom of Saudi Arabia (also responsible for United Arab Emirates, Kuwait, Bahrain, Qatar and Oman), South Korea and Ukraine.

The company also has partnerships with local distributors (business-to-business) to complete the offer of leading generic drug companies in local markets.

Pendopharm

Pendopharm is a division of Pharmascience Inc. founded in 2011, which is responsible for marketing products in Canada that were designed in other countries. [30] In addition to marketing, the division is involved in licensing, partnership, and development of specialty prescription medicines and consumer healthcare products.

For prescription products, Pendopharm specializes in several different therapeutic classes: gastroenterology, orthopedics and specialty medicine.

For consumer products, Pendopharm offers over-the-counter and behind-the-counter products for adults and children in the following therapeutic areas: allergies, colds and coughs, gastroenterology, nose care, and pediatrics.

Royalmount Laboratories

Royalmount Laboratories is a division of Pharmascience Inc. in analytical services founded in 2019. The laboratory specializes in bioanalytics and cannabis testing. It is equipped to meet the tests required by Health Canada for companies legally authorized to produce, sell or distribute cannabis. [31]

Related Research Articles

<span class="mw-page-title-main">Economy of Quebec</span>

The economy of Quebec is diversified and post-industrial with an average potential for growth. It is highly integrated with the economies of the rest of Canada and the United States. Manufacturing and service sectors dominate the economy.

Noovo is a Canadian French-language terrestrial television network owned by the Bell Media subsidiary of BCE Inc. The network has five owned-and-operated and three affiliated stations throughout Quebec. It can also be seen over-the-air in some bordering markets in the provinces of Ontario and New Brunswick, and in some other parts of Canada on cable television or direct broadcast satellite.

Léger is the largest Canadian-owned market research and analytics company, with more than 600 employees in eight Canadian and US offices. The company was founded in 1986 by the father and son duo Marcel Léger, former environment minister of Quebec, and Jean-Marc Léger, economist. Previously, the company was known as Léger & Léger (1986–1996) and Léger Marketing (1996–2013).  It is now led solely by Jean-Marc Léger.

Bausch Health Companies Inc. is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products. Bausch Health's business model is primarily focused on acquiring small pharmaceutical companies and then sharply increasing the prices of the drugs these companies sell.

Les Films Séville was a Canadian film distributor company. First based on Saint-André Boulevard in 1983, it moved its operations in 1993 to Saint Laurent Boulevard, as the Canadian branch of Republic Pictures Home Video and Turner Home Entertainment, distributing releases from the two companies into Canada. The company distributed Entertainment One’s movies in Quebec.

<span class="mw-page-title-main">Montreal Supra</span> Former soccer team in Montreal, Quebec

Montreal Supra was a Canadian professional soccer club based in Montreal, Quebec that played in the Canadian Soccer League from 1988 to 1992.

Eurofins Scientific SE is a French group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments.

<span class="mw-page-title-main">Camso</span> Canadian automotive parts manufacturing company

Camso, formerly known as Camoplast Solideal, is a Canadian company that is a manufacturer and service supplier of products for off-the-road vehicles. They serve the material handling, construction, agriculture and powersport industries. Camso manufactures and distributes pneumatic, airless and solid tires, tracks, driven and trailed conversion track systems and OEM undercarriages. The company was founded in 1982, and is based in Magog, Quebec, Canada. It also has branches and manufacturing plants in America, Asia and Europe. Camso Research Centers are in Magog, Ghent, Sri Lanka, Shanghai & Ho Chi Minh City and has a global workforce of more than 8000 employees.

<span class="mw-page-title-main">Agence nationale de sécurité du médicament et des produits de santé</span>

Agence nationale de sécurité du médicament et des produits de santé (ANSM) superseded the tasks and duties of Agence française de sécurité sanitaire des produits de santé (AFSSAPS) on 1 May 2012. It is responsible for assessing the benefits and risks associated with the use of drugs and other medical products throughout their life-cycle. ANSM assesses the safety, efficacy and quality of these products and must balance patient safety with access to novel therapies.

<span class="mw-page-title-main">Pharmaceutical industry in Switzerland</span> Overview of the pharmaceutical industry in Switzerland

The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. It contributes 5.7% of the gross domestic product of Switzerland and 30% of the country's exports. In 2017 about 30% of Swiss exports were chemical products. In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion.

<span class="mw-page-title-main">Adrien D. Pouliot</span> Canadian politician (born 1957)

Adrien D. Pouliot is a Quebec lawyer, businessman and politician.

<span class="mw-page-title-main">Roski</span>

Roski Composites inc. is a company located in Roxton Falls, Quebec, Canada. The 134 000 ft2 plant specializes in producing molded parts made from composite materials, mainly for the ground transportation, construction and marine industries in North America.

<span class="mw-page-title-main">La Cordée</span>

La Cordée is a Montreal-based chain of outdoor recreation and sports stores established in 1953. The company is the property of two non profit organizations and all its non-reinvested profits are administered by La Fondation scoute La Cordée.

Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019.

<span class="mw-page-title-main">Alexandre Taillefer</span> Canadian entrepreneur from Quebec

Alexandre Taillefer is a Canadian entrepreneur from Quebec. He is the founder and managing partner of XPND Capital, a private equity firm.

<span class="mw-page-title-main">C2 Montréal</span> Canadian annual creativity and business conference

C2 Montréal is a nonprofit organization which holds an annual 3-day international conference in Montreal, Quebec. Its intention is to stimulate the economy in the province of Quebec by facilitating collaboration and networking within the business and creative communities. The conference was conceived by the Montreal-based creative agency Sid Lee in partnership with Cirque du Soleil and has been held every year in May since 2012. C2 Montréal is subsidized by profits generated by C2 International Inc.

<span class="mw-page-title-main">COVID-19 pandemic in Quebec</span> COVID-19 viral pandemic in Quebec, Canada

The COVID-19 pandemic in Quebec was part of the global pandemic of coronavirus disease 2019 (COVID-19), a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

<span class="mw-page-title-main">CHSLD Herron</span> Long-term care nursing home in Dorval, Quebec

CHSLD Herron, also known as Résidence Herron, was a long-term care facility located in Dorval, Quebec, Canada; a suburb of Montreal; near Lake Saint Louis. The property was acquired by Katasa Groupe in 2015.

<span class="mw-page-title-main">COVID-19 pandemic in Montreal</span> Ongoing COVID-19 viral pandemic in Montreal, Quebec, Canada

The COVID-19 pandemic in Montreal is part of an ongoing global pandemic of coronavirus disease 2019 (COVID-19), a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Until April 2021, Montreal was the worst affected health region in Canada. Despite being surpassed by Toronto in total number of cases, Montreal still has the highest total death count and the highest death rate in Canada, with the death rate from COVID-19 being two times higher on the island of Montreal than in the city of Toronto due in large part to substantial outbreaks in long-term care homes. Montreal is Canada's second most populous city, the largest city in Quebec, and the eighth most populous city in North America.

The boroughs of Montreal, like the rest of Canada and the world, have been individually impacted by the COVID-19 pandemic.

References

  1. ↑ "Pharmascience in Brief". Pharmascience. Retrieved 23 June 2015.
  2. ↑ Décarie, Jean-Philippe (2020-04-23). "Pas de pénurie en vue pour les génériques". La Presse (in French). Retrieved 2020-10-29.
  3. ↑ "Des médicaments fabriqués ici". Le Courrier du Sud (in Canadian French). 2019-05-23. Retrieved 2020-10-29.
  4. ↑ "La longue quête de la recette parfaite". www.lesaffaires.com (in French). Retrieved 2020-11-20.
  5. ↑ Duhamel, Pierre (14 August 2014). "Nos champions à l'international : Pharmascience". L’actualité (in Canadian French). Retrieved 2020-11-20.
  6. ↑ Gouron, Richard; Tallineau, Alexis; Haraux, Elodie; Klein, Céline (July 2019). "Torticolis de l'enfant : ne pas méconnaître une dislocation rotatoire C1–C2". La Presse Médicale. 48 (7–8): 871–873. doi: 10.1016/j.lpm.2019.07.013 . ISSN   0755-4982. PMID   31399241.
  7. ↑ Dolinine, Constantin (1999). "Le problème des genres du discours quarante-cinq ans après Bakhtine". Langage et société. 87 (1): 25–40. doi:10.3406/lsoc.1999.2852. ISSN   0181-4095.
  8. ↑ Galtier, Bénédicte (1999). "Les temps partiels : entre emplois choisis et emplois "faute de mieux"". Économie et Statistique. 321 (1): 57–77. doi:10.3406/estat.1999.6188. ISSN   0336-1454.
  9. ↑ "Les actions de PanGeo Pharma vendus". Le Droit. November 13, 2003.
  10. ↑ Massé, Isabelle (2011-05-17). "Pharmascience s'agrandit et crée 180 emplois". La Presse (in French). Retrieved 2020-12-02.
  11. ↑ Kendall, K. (2020-11-27), "Advanced Composites at Aston Martin Lagonda", Design, Manufacturing & Application of Composites, CRC Press, pp. 27–34, doi:10.1201/9781003076155-12, ISBN   978-1-003-07615-5, S2CID   229473762 , retrieved 2020-12-02
  12. ↑ "New generic drug distribution centre opens in Dorval". montrealgazette. Retrieved 2020-12-10.
  13. ↑ "Des médicaments montréalais bientôt vendus en Corée du Sud". www.lesaffaires.com (in French). Retrieved 2020-12-10.
  14. ↑ "Le nouvelle vie de Pharmascience". La Presse+ (in French). 2016-06-21. Retrieved 2020-12-11.
  15. ↑ "Des médicaments fabriqués ici". Le Courrier du Sud (in Canadian French). 2019-05-23. Retrieved 2020-12-11.
  16. ↑ "Pharmascience agrandit ses installations". Le Devoir (in French). 23 June 2015. Retrieved 2020-12-18.
  17. ↑ ICI.Radio-Canada.ca, Zone Économie- (22 June 2015). "Pharmascience investit 55,7 millions à Montréal". Radio-Canada.ca (in Canadian French). Retrieved 2020-12-18.
  18. ↑ "Pharmascience Inc. launches Royalmount Laboratories, a new analytical service division in Montreal". markets.businessinsider.com. Retrieved 2020-12-18.
  19. ↑ "The Ceremony of Partnership and Technology Transfe". www.alfayhaaco.com. Retrieved 2020-12-18.
  20. 1 2 Scali, Dominique (27 September 2016). "De livreur à vélo à dirigeant d'une compagnie". Le Journal de Montréal. Retrieved 2020-12-21.
  21. 1 2 "Conseil de famille". La Presse+ (in French). 2017-12-27. Retrieved 2020-12-21.
  22. 1 2 "Conseil de famille". La Presse+ (in French). 2017-12-27. Retrieved 2021-01-08.
  23. ↑ Scali, Dominique (27 September 2016). "De livreur à vélo à dirigeant d'une compagnie". Le Journal de Montréal. Retrieved 2021-01-08.
  24. ↑ "The Morris and Rosalind Goodman Family Foundation - Home". Morris and Rosalind Goodman Family Foundation. Retrieved 2021-01-14.
  25. ↑ "2,5 millions pour le cancer". La Presse (in French). 2014-06-09. Retrieved 2021-01-14.
  26. ↑ "Philanthropes honorés". La Presse (in French). 2011-06-08. Retrieved 2021-01-14.
  27. ↑ "Cultiver la différence | McGill-Queen's University Press". www.mqup.ca. Retrieved 2021-01-14.
  28. ↑ "Dr David Goodman". Bloomberg.
  29. ↑ "Des médicaments fabriqués ici". Le Courrier du Sud (in Canadian French). 2019-05-23. Retrieved 2021-02-05.
  30. ↑ "Le nouvelle vie de Pharmascience". La Presse+ (in French). 2016-06-21. Retrieved 2021-02-10.
  31. ↑ "Pharmascience Inc. launches Royalmount Laboratories, a new analytical service division in Montreal". markets.businessinsider.com. Retrieved 2021-02-10.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.